Fisher Funds Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43M Buy
1,007,864
+146,900
+17% +$7.98M 1.22% 22
2026
Q1
$54M Buy
860,964
+490,387
+132% +$39.2M 1.58% 19
2025
Q4
$35.5M Sell
370,577
-112,639
-23% -$11M 0.92% 35
2025
Q3
$47.2M Sell
483,216
-465,878
-49% -$48.2M 1.25% 23
2025
Q2
$102M Sell
949,094
-112,798
-11% -$11.4M 2.42% 12
2025
Q1
$107M Hold
1,061,892
2.6% 11
2024
Q4
$94.7M Buy
+1,061,892
New +$93.5M 2.28% 13

Other funds holding BSX

Fisher Funds Management's BSX Position: Q2 2026 in Review

Fisher Funds Management increased its Boston Scientific (BSX) stake by 17% in Q2 2026, buying an estimated $7.98M and bringing the position to 1,007,864 shares worth $43M. The position accounts for 1.22% of the portfolio, ranked #22.

Fisher Funds Management first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $107M in Q1 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Fisher Funds Management held 1,007,864 shares of Boston Scientific worth $43M as of Q2 2026.
  • Fisher Funds Management bought 146,900 Boston Scientific shares in Q2 2026, an estimated $7.98M.
  • Boston Scientific made up 1.22% of Fisher Funds Management's portfolio in Q2 2026, its #22 holding.
  • Fisher Funds Management first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Fisher Funds Management's Boston Scientific position peaked at $107M in Q1 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fisher Funds Management's 13F filing for Q2 2026, filed 14 Jul 2026.